EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,137,000 | -33.4% | 975,103 | -23.8% | 2.19% | -42.3% |
| Q3 2017 | $13,727,000 | -30.8% | 1,279,267 | -33.8% | 3.79% | -52.1% |
| Q2 2017 | $19,839,000 | +12.6% | 1,933,582 | 0.0% | 7.92% | +9.9% |
| Q1 2017 | $17,615,000 | -27.1% | 1,933,582 | 0.0% | 7.21% | -37.8% |
| Q4 2016 | $24,170,000 | +20.1% | 1,933,582 | 0.0% | 11.59% | +12.2% |
| Q3 2016 | $20,129,000 | +3.0% | 1,933,582 | 0.0% | 10.33% | -12.4% |
| Q2 2016 | $19,549,000 | +10.5% | 1,933,582 | 0.0% | 11.80% | +1.4% |
| Q1 2016 | $17,692,000 | -20.2% | 1,933,582 | 0.0% | 11.64% | -36.1% |
| Q4 2015 | $22,169,000 | – | 1,933,582 | – | 18.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |